Goal and Purpose
Colorectal Cancers, Lung Cancer, Malignant Melanoma, Non-Small Cell Lung Cancer (NSCLC), Papillary Thyroid Carcinoma, Non Hodgkin Lymphoma (NHL), Response to EGFR inhibitors (TKIs) treatment , Erbitux (Cetuximab), Vectibix (Panitumumab)